期刊文献+

凝血因子Ⅶ水平及其基因多态性与PTE的相关研究

Correlation of coagulation factor Ⅶ gene polymorphism and its level to pulmonary thromboembolism
下载PDF
导出
摘要 目的探讨FⅦ基因R353Q多态性及血浆FⅦa水平与PTE的相关性。方法收集肺血栓栓塞症(PTE)患者198例和对照组212例;采用PCR-PFLP检测FⅦ基因R353Q多态性,ELISA法测定血浆FⅦa水平。结果①FⅦ基因R353Q单核苷酸多态性(SNP)基因分布频率和等位基因携带频率在病例与对照组差异均无统计学意义(P>0.05)。②血浆FⅦa水平PTE组与对照组比较,差异有显著性意义(P=0.000)。③通过非条件Logistic回归模型校正后,吸烟、纤维蛋白原和血浆FⅦa水平是PTE患者的独立危险因素。结论高血浆FⅦa水平是PTE患者的独立危险因素;FⅦ基因R353Q多态性可能不是PTE患者的独立危险因素。 Objective To investigate the correlation of coagulation factor FⅦ gene R353Q mutation and its plasma level to pulmonary thromboembolism (PTE). Methods The study selected 198 patients with PTE as the ob- servation group and 212 healthy people as controls. Polymerase chain reaction-restriction fragment length polymor- phism (PCR-RFLP) was applied to detect the polymorphism of FⅦ gene R353Q and enzyme-linked immune sorbent assay (ELISA) was adopted to determine the plasma level of F Ⅶa. Results ① There was no significant difference in the SNP genotyping distribution frequency and the R/Q-allele frequency between the two groups ( P 〉 0. 05 ). ② The plasma level of FⅦa was significantly higher in the observation group than in the controls (P = 0. 000). ③ Multifactor logistic regression analysis showed that plasma FⅦa level, fibrinogen and smoking were independent risk factors for PTE patients. Conclusion High plasma F Ⅶ a level is a common risk factor for PTE patients. The F Ⅶ R353Q polymorphism may not be an independent risk factor for PTE patients.
出处 《临床肺科杂志》 2014年第2期195-198,共4页 Journal of Clinical Pulmonary Medicine
基金 新疆自治区自然科学基金(No:2011211A062)
关键词 凝血因子Ⅶ基因 多态性 单核苷酸 肺血栓栓塞症 coagulation factor Ⅶ gene polymorphism mononucleotide pulmonary thromboembolism
  • 相关文献

参考文献11

  • 1于丽侠,杨晓红,邬超,谷春玲.肺血栓栓塞症患者PROS1T1378C多态性探讨[J].临床肺科杂志,2011,16(4):533-535. 被引量:2
  • 2Zee RY, Glynn RJ, Cheng S, et al. An evaluation of candidate genes of inflammation and thrombosis in relation to the risk of pul- monary thromboembolism: The Women's Genome Health Study [ J]. Circ Cardiovasc Genet, 2009, 2:57 - 62.
  • 3Eroglu A, Oztiirk A, Cam R, et al. No significant association be- tween the promoter region polymorphisms of factor VH gene and risk of venous thrombosis in cancer patients[ J]. Exp Oncol, 2010, 32 (1) :15 -18.
  • 4Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute pulmonary Em- bolism of the European Society of Cardiology ( ESC ) [ J ]. Eur Heart J, 2008, 29:2276-2315.
  • 5Tsai AW, Cushman M, Rosamond WD, et al. Coagulation fac- tors, inflammation markers, and pulmonary thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE) [J]. Am J Med, 2002,113:636 -642.
  • 6杜贻萌,路方红,王克志,吴凡,田奇,孙慧,商清.凝血因子Ⅶ及其基因MspI多态性与高血压合并脑梗死的相关性[J].中国动脉硬化杂志,2004,12(6):691-694. 被引量:5
  • 7Koster T, Rosendaal FR, Reitsma PH, et al. Factor VII and fi- brinogen levels as risk factors for venous thrombosis. A case-con- trol study of plasma levels and DNA polymorphisms-the Leiden Thrombophilia Study ( LETS ) [ J ]. Thromb Haemost, 1994,71 (6) :719 -722.
  • 8Cushman M. Inherited risk factors for venous thrombosis[ J]. He- matology Am Soc Hematol Educ Program, 2005:452 -457.
  • 9贺颖,封青川,杨冬之,齐华,郑红.河南汉族深静脉血栓形成患者凝血因子Ⅶ基因多态性检测[J].郑州大学学报(医学版),2011,46(1):59-63. 被引量:5
  • 10Kruthika-Vinod TP, Dindagur N, Rita C, et al. Coagulation factor VR R353Q polymorphism and the risk of puerperal cerebral venous thrombosis [ J ]. Journal of Clinical Neuroscience, 2012, ( 19 ) : 190 - 191.

二级参考文献23

  • 1Yong Yong SHI,Lin HE.SHEsis,a powerful software platform for analyses of linkage disequilibrium,haplotype construction,and genetic association at polymorphism loci[J].Cell Research,2005,15(2):97-98. 被引量:381
  • 2[1]Takano K, Yamaguchi T, Okada Y, Uchida K, Kisiel W, Kato H. Hypercoagulability in acute ischaemic stroke: analysis of the extrinsic coagulation reactions in plasma by a highly sensitive automated method. Thromb Res, 1990, 58:481-491
  • 3[2]Kato K, Ali Elayed Y, Namoto M, Nakagawa K, SueishiK . Enhanced expression of tissue factor activity in the atherosclerotic aortas of eholesterol-fed ralbbits.Thromb Res, 1996, 82 (4): 335-347
  • 4[3]Pankow JS, Folsom AR, Shahar E, Tsai MY, Jeffery RW, Wing RR. Weightlose induced changes in plasma factor Ⅶ coagulant activity and relation to the factor Ⅶ Arg/Gln 353 polymorphism in moderately obese adults. Thromb Haemost,1998, 78:784-789
  • 5[4]Kario K, Miyata T, Sakata T, Yamada T, Nakarmura S, Kato H. Fluorogenic assay of activated factor Ⅶ. Plasma factor Ⅶ a levels in relation to arterial cardiovascular diseases in Japandse. Arterioscler Thromb, 1994, 14 (2): 265-269
  • 6[6]HeywoodDM, CarterAM, CattoAJ, BamfordJM, Grant PJ. Polymorphisms of the factor Ⅶ gene and circulating FⅦc levels in relation to acute cerebrovascular disease and post stroke mortality. Stroke, 1997, 28:816-827
  • 7[7]Smith FB, Lee A J, Fowkes FGR, Price JF, Rumley A, Lowe GD. Hemostatic factor as predictors of ischaemic heart disease and stroke in the Edinburgh Artery Study. Arterioecler Thromb Vasc Biol, 1997, 17:3 321-325
  • 8[8]Green F, Kelleher C, Wilke S, Temple A, Meade T, Humphries S. A common genetic Polymorphism associated with lower coagulation factor Ⅶ levels in healthy individuals. Arterioscler Thromb, 1991, 11:540-546
  • 9[9]Lane A, Green F, Scarabin PY, Nicaud V, Bara L, Humphries S, et al. Factor Ⅶ Arg/Gln353 polymorphism determines factor Ⅶ coagulant activity in patients with myocardial infarction (M1) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study. Atherasclerosis, 1996,119 (1): 119-127
  • 10[10]Nishiuma S, Kario K, Nakanishi K, Yakushijin K, Kageyama G, Matsunaka T,et al. Factor Ⅶ R353Q polymorphism and lacunar stroke in Japanese hypertensive patients and normotensive controls. Blood Coagul Fibrinolysis, 1997, 8(8): 525-530

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部